Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ABBV

AbbVie (ABBV)

AbbVie Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ABBV
DateTimeSourceHeadlineSymbolCompany
08/29/20198:45AMPR Newswire (US)AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development ProgramNYSE:ABBVAbbVie Inc
08/28/201910:20AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
08/27/20199:17AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
08/27/20198:00AMPR Newswire (US)AbbVie to Present at the Morgan Stanley Healthcare ConferenceNYSE:ABBVAbbVie Inc
08/26/201911:40AMDow Jones NewsForm 8.3 -Allergan PlcNYSE:ABBVAbbVie Inc
08/23/201910:51AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
08/22/201911:05AMDow Jones NewsForm 8.3 - [AbbVie. Inc]NYSE:ABBVAbbVie Inc
08/22/201910:55AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
08/21/201910:56AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
08/20/20194:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
08/20/201910:58AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
08/19/201910:41AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
08/16/20194:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
08/16/20192:16PMDow Jones NewsAbbVie Gets FDA OK for Rheumatoid Arthritis Drug RinvoqNYSE:ABBVAbbVie Inc
08/16/201912:43PMPR Newswire (US)AbbVie Receives FDA Approval of RINVOQ™ (upadacitinib), an Oral JAK Inhibitor For The Treatment of Moderate to Severe Rheum...NYSE:ABBVAbbVie Inc
08/16/201910:48AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
08/15/201910:44AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
08/14/201910:51AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
08/13/201910:47AMDow Jones NewsForm 8.3 -Allergan PlcNYSE:ABBVAbbVie Inc
08/12/201911:09AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
08/09/201910:51AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
08/08/201910:41AMDow Jones NewsForm 8.3 -Allergan PlcNYSE:ABBVAbbVie Inc
08/07/201911:03AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
08/06/201910:30AMDow Jones NewsForm 8.3 - [Allergan Plc.]NYSE:ABBVAbbVie Inc
08/05/201912:35PMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:ABBVAbbVie Inc
08/05/201910:53AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
08/05/20198:30AMPR Newswire (US)AbbVie Submits New Drug Application to US FDA for Investigational Elagolix for Management of Heavy Menstrual Bleeding Associa...NYSE:ABBVAbbVie Inc
08/02/20195:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
08/02/201910:53AMDow Jones NewsForm 8.3 -Allergan PlcNYSE:ABBVAbbVie Inc
08/02/20198:45AMPR Newswire (US)AbbVie's MAVIRET™ (glecaprevir/pibrentasvir) Approved by European Commission to Shorten Treatment Duration to Eight Weeks f...NYSE:ABBVAbbVie Inc
 Showing the most relevant articles for your search:NYSE:ABBV